PD
CRNX icon

Point72 (DIFC)’s Crinetics Pharmaceuticals CRNX Stock Holding History

Point72 (DIFC)’s Portfolio CRNX Stock Details CRNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$611K Buy
14,672
+9,522
+185% +$304K 0.04% 244
2025
Q2 		$148K Buy
+5,150
New +$159K 0.01% 841
2025
Q1 		– Sell
-3,969
Closed -$203K – 1731
2024
Q4 		$203K Buy
+3,969
New +$222K 0.01% 870

Other funds holding CRNX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

Point72 (DIFC)'s CRNX Position: Q3 2025 in Review

Point72 (DIFC) increased its Crinetics Pharmaceuticals (CRNX) stake by 185% in Q3 2025, buying an estimated $304K and bringing the position to 14,672 shares worth $611K. The position accounts for 0.04% of the portfolio, ranked #244.

Point72 (DIFC) first reported a position in CRNX in Q4 2024 and has held it in 3 quarters since. 225 funds tracked by Wall St. Rank hold CRNX as of Q3 2025.

  • Point72 (DIFC) held 14,672 shares of Crinetics Pharmaceuticals worth $611K as of Q3 2025.
  • Point72 (DIFC) bought 9,522 Crinetics Pharmaceuticals shares in Q3 2025, an estimated $304K.
  • Crinetics Pharmaceuticals made up 0.04% of Point72 (DIFC)'s portfolio in Q3 2025, its #244 holding.
  • Point72 (DIFC) first reported a position in Crinetics Pharmaceuticals in Q4 2024 and has held it in 3 quarters since.
  • 225 funds tracked by Wall St. Rank held Crinetics Pharmaceuticals as of Q3 2025.

Based on Point72 (DIFC)'s 13F filing for Q3 2025, filed 14 Nov 2025.